The burden of bacterial antimicrobial resistance in the WHO African region in 2019: a cross-country systematic analysis

  28 March 2024

Antimicrobial resistance (AMR) is a significant global health challenge, with a disproportionate burden in low-income and middle-income countries. This study provides a comprehensive set of regional and country-level estimates of AMR burden in the WHO African region. The study estimated deaths and disability-adjusted life-years (DALYs) attributable to and associated with AMR for 23 bacterial pathogens and 88 pathogen-drug combinations for countries in the WHO African region in 2019. The largest fatal AMR burden was attributed to lower respiratory and thorax infections, bloodstream infections, intra-abdominal infections, and tuberculosis. Seven leading pathogens were collectively responsible for 821,000 deaths associated with resistance in the region. The study reveals a high level of AMR burden for several bacterial pathogens and pathogen-drug combinations in the WHO African region, highlighting the urgent need to address the burden of AMR in Africa.

Further reading: Oxford University
Author(s): Oxford University
Effective Surveillance  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

LifeArc

Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS





AMR NEWS

Every two weeks in your inbox

Because there should be one newsletter that brings together all One Health news related to antimicrobial resistance: AMR NEWS!

Subscribe

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed